Polyp. Nasal polyp
Conditions
Interventions
Intervention 1: Intervention group: Postoperatively, patients in the first group will receive a 1-month course of oral prednisolone at a dose of 0.5 mg/kg of body weight. This will be followed by a 3-
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Without underlying diseases including cystic fibrosis, Kartagener syndrome, Wegener's vasculitis, vasculitides, sarcoidosis, and rheumatologic diseases. They should not have taken zinc as a dietary supplement in the past 3 months. The patients included in the study must not have received systemic corticosteroid therapy or undergone previous sinus surgery.
Exclusion criteria
Exclusion criteria: No postoperative follow-up. Any histopathological diagnosis other than sinonasal polyposis (SNP), such as malignancies. No postoperative medication use.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Polyp recurrence. Timepoint: Before the intervention, and at 1, 3, and 6 months after the intervention. Method of measurement: Clinical examination and Sino-nasal Outcome Test (SNOT-22) questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMatin Ghazizadeh
Shahid Beheshti University of Medical Sciences
Outcome results
None listed